Madrigal Pharmaceuticals (MDGL) Net Income Growth (5y) (2015 - 2026)
Madrigal Pharmaceuticals (MDGL) Net Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Madrigal Pharmaceuticals | 16.15 Bn | 15.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.81% |
| Dec 31, 2025 | 2.13% |
| Sep 30, 2025 | -13.89% |
| Jun 30, 2025 | 2.98% |
| Mar 31, 2025 | -15.15% |
| Dec 31, 2024 | 13.29% |
| Sep 30, 2024 | -37.79% |
| Jun 30, 2024 | -50.43% |
| Mar 31, 2024 | -57.74% |
| Dec 31, 2023 | -17.35% |
| Sep 30, 2023 | -63.22% |
| Jun 30, 2023 | -66.31% |
| Mar 31, 2023 | -64.60% |
| Dec 31, 2022 | -23.32% |
| Sep 30, 2022 | -57.18% |
| Jun 30, 2022 | -53.33% |
| Mar 31, 2022 | -57.16% |
| Dec 31, 2021 | -52.80% |
| Sep 30, 2021 | -35.04% |
| Jun 30, 2021 | -84.59% |